Document:

exv10w31

 

EXHIBIT 10.31

Agreement No. 98-0228A

AMENDMENT TO LICENSE AGREEMENT 98-0228

This Amendment is made effective as of the 16th day of April, 2007, by and between Wisconsin
Alumni Research Foundation (“WARF”), a nonstock, nonprofit Wisconsin corporation, and TomoTherapy
Incorporated (“TomoTherapy”), a corporation organized and existing under the laws of Wisconsin.

WITNESSETH

     WHEREAS, WARF and TomoTherapy entered into license agreement 98-0228 made effective February
22,1999 (the “Agreement”); and

     WHEREAS, WARF and TomoTherapy desire to amend the Agreement to clarify certain rights and
obligations under the Agreement.

     NOW THEREFORE, in consideration of the mutual covenants and agreements set forth below and in
the Agreement, the parties covenant and agree as follows:

	1.	 	WARF has not initiated any infringement actions related in any Way to the Licensed Patents.
As of the date of this Amendment WARF has no plans to initiate any infringement action
related in any way to the use of the Licensed Patents.
	 
	2.	 	As of the date of this Amendment, WARF has not received notice of any declaratory judgment
action brought against WARF related in any way to the Licensed Patents.
	 
	3.	 	The third sentence of Section 9A of the Agreement is hereby deleted in its entirety
and replaced with the following sentence:
	 
	 	 	“WARF shall have the right to determine the best course of action to resolve such
infringement, however, in no event will WARF grant a license to any such alleged infringer
to practice the inventions of the Licensed Patents thereafter without a sublicense
directly from TomoTherapy.”
	 
	4.	 	The fourth and fifth sentences of Section 9A of the Agreement are hereby deleted in their
entirety.
	 
	5.	 	The first sentence of Section 9B of the Agreement shall be deleted in its entirety and
replaced with the following sentence:
	 
	 	 	“In the event of a declaratory judgment action brought by a third party, WARF shall have
the exclusive right to defend the Licensed Patents by litigation or settlement, provided,
however, that in no event will WARF grant a license to the third party instituting such
action that would allow such third party to practice the inventions of the Licensed Patents
thereafter without such third party obtaining a sublicense directly from TomoTherapy.”

Page 1 of 2

 

	6.	 	Section 9C of the Agreement shall be deleted in its entirety.

	7.	 	Except as otherwise provided in this Amendment, all terms and conditions previously set forth
in the Agreement shall remain in effect as set forth therein and all defined terms used in
this Amendment shall have the same meaning as indicated in the Agreement. In the event that
this Amendment and the Agreement are inconsistent, the terms and provisions of this Amendment
shall supercede the terms and provisions of the Agreement, but only to the extent necessary to
satisfy the purpose of this Amendment. Each party hereto represents to the other that it has
the full authority to execute, deliver and perform this Amendment in accordance with its
terms.

     IN WITNESS WHEREOF, the parties hereto have duly executed this Amendment on the dates
indicated below.

	 	 	 	 	 	 	 
	WISCONSIN ALUMNI RESEARCH FOUNDATION
	 
	 	 	 	 	 	 
	By:

	 	/s/  Craig Christianson
	 	 	 	Date: 5/1/07
	 

	 	 	 	 	 	 
	 

	 	Craig Christianson, Director of Licensing	 	 	 	 
	 
	 	 	 	 	 	 
	TOMOTHERAPY INCORPORATED	 	 	 	 
	 
	 	 	 	 	 	 
	By:

	 	/s/  Shawn D. Guse
	 	 	 	Date: April 18, 2007
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	 	 	 

Page 2 of 2exv10w32

 

Exhibit 10.32

AMENDMENT AND WAIVER AGREEMENT

     This
Amendment and Waiver Agreement (this “Agreement”) is
made and entered into effective as of
September 20, 2007, by and among TomoTherapy Incorporated, a Wisconsin corporation
(the “Company”), and the undersigned Persons and entities listed on Exhibit A
hereto (the “Investors”). Capitalized terms not otherwise defined herein shall have the
meanings ascribed to such terms in the Investment Agreement (as defined below).

RECITALS

     WHEREAS, the Investors and the Company have entered into that certain Amended and Restated
Investment Agreement dated as of February 8, 2007 (as modified by this Agreement, the
“Investment Agreement”); and

     WHEREAS, certain Rightholders desire to implement a Demand Registration of a portion of such
Investors’ Registrable Securities pursuant to a Registration Statement on Form S-1 that the Company
anticipates filing with the Securities and Exchange Commission in September 2007 (the “Proposed
Offering”); and

     WHEREAS, in connection with the Proposed Offering, the Company and the Investors desire to
allow the registration under the Securities Act of a portion of the Common Shares held by Persons
other than the Investors but for which the orderly sale of such Common Shares in the Proposed
Offering would likely be in the best interests of the Investors.

     NOW, THEREFORE, in consideration of the mutual representations, warranties and covenants
contained herein, and other good and valuable consideration, the receipt and sufficiency of which
are hereby acknowledged, the parties hereto agree as follows:

AGREEMENT

     1. Demand Registration. The Company and each Investor hereby acknowledges that the
Proposed Offering constitutes a Demand Registration under Section 2.1(a) of the Investment
Agreement.

     2. Amendment of Section 2.1(a). Each Investor hereby agrees that for purposes of the
Proposed Offering only:

     (a) the fourth sentence of Section 2.1(a) shall be deleted and replaced with the following
sentence:

     “Notwithstanding any other provision of this section, if the managing
underwriter determines that marketing factors require a limitation on the number of
shares to be underwritten, then the Company shall so advise the Rightholders which
would otherwise be underwritten pursuant to this provision, and the number of shares
that may be included in the underwriting shall be allocated

 

 

among the Rightholders and the Other Shareholders (as defined below), subject
to the Participation Cap (as defined below), in proportion, as nearly as
practicable, to the respective amounts of Investor Eligible Securities (as defined
below) held by such Rightholders and Other Eligible Securities held by such Other
Shareholders.”

     3. Waiver of Restriction on Grants of Registration Rights. The Company and each
Investor hereby waives the provisions of Section 2.8 of the Investment Agreement to the
extent necessary to permit the registration under the Securities Act in the Proposed Offering of;

               (a) Common Shares held by any Investor that are: (i) Registrable Securities; (ii) Common
Shares acquired prior to the Company’s initial public offering, which are not Registrable
Securities; and (iii) Common Shares issued or issuable upon the exercise of options or warrants
that vested prior to or on August 31, 2007 (collectively, the “Investor Eligible
Securities”); and

               (b) Common Shares held by any Persons other than Investors (“Other Shareholders”) that
are (i) Common Shares acquired prior to the Company’s initial public offering, which are not
Registrable Securities; and (ii) Common Shares issued or issuable upon the exercise of options or
warrants that vested prior to or on August 31, 2007 ((i) and (ii) collectively, the “Other
Eligible Securities”);

provided that the maximum number of Common Shares to be sold by the Other Shareholders in
the Proposed Offering may not exceed thirty percent (30%) of the total number of Common Shares sold
in the Proposed Offering (the “Participation Cap”).

     4. Waiver of Notice Requirements. The Company and each Investor hereby waives all
notice and timing requirements set forth in Section 2.1 of the Investment Agreement as they
relate to the Proposed Offering and acknowledges that this Agreement constitutes sufficient notice
under the Investment Agreement.

     5. Effectiveness; Miscellaneous.

               (a) This Agreement shall become effective as of the first date first set forth above. Upon
the earlier to occur of (i) the consummation of the Proposed Offering, or (ii) December 31, 2007,
the amendments and waivers effected by this Agreement shall no longer be in effect and the
Agreement shall be automatically amended to read in its entirety as it read prior to the
effectiveness hereof (except that the Proposed Offering shall be considered a demand registration
thereunder for purposes of the number of demand registrations required to be effected by the
Company).

               (b) This Agreement and the Investment Agreement constitute the entire agreement and
understanding of the parties with respect to the subject matter hereof and such agreements
supersedes any and all prior agreements and understandings, oral or written, relating to the
subject matter hereof.

 

 

               (c) Section headings used herein are for convenience of reference only and are not to affect
the construction of, or to be taken into consideration in interpreting, this Agreement.

               (d) The laws of the State of Wisconsin shall govern the interpretation, validity and
performance of the terms of this Agreement, regardless of the law that might be applied under
applicable principles of conflicts of laws.

               (e) Each reference to a party hereto shall be deemed to include its successors and assigns,
all of whom shall be bound by this Agreement and to whose benefit the provisions of this Waiver
shall inure.

               (f) This Agreement may be executed via facsimile or by other electronic signature.

               (g) This Agreement may be executed in any number of counterparts, each of which shall be an
original but all of which, when taken together, shall constitute but one instrument.

[Signature pages follow]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	COMPANY:

TOMOTHERAPY INCORPORATED

 	 
	 	By:  	/s/
Frederick A. Robertson 	 
	 	 	Frederick A.  Robertson 	 
	 	 	Chief Executive Officer 	 
	 

[Signature Page to Amendment and Waiver Agreement]

	 	 	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	 

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 

	 	 	 	INVESTOR:
	 
	 	 	 	 
	 

	 	 	 	/s/ Paul J. Reckwerdt 
	 

	 	 	 	 
	 

	 	 	 	Paul J. Reckwerdt
	 
	 	 	 	 
	 

	 	Notices:
	 	Paul J. Reckwerdt
	 

	 	 	 	c/o TomoTherapy Incorporated
	 

	 	 	 	1240 Deming Way
	 

	 	 	 	Madison, WI 53717-1954
	 

	 	 	 	Phone: (608) 824-2849
	 

	 	 	 	Email: preckwerdt@tomotherapy.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

ASCENSION HEALTH

a Missouri nonprofit corporation as fiscal agent and

nominee for certain of its wholly-owned subsidiaries

 	 
	 	By:  	/s/
Anthony J. Speranzo 	 
	 	 	Anthony J. Speranzo 	 
	 	 	Senior Vice President & Chief Financial Officer 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Attn: Matt Hermann
	 

	 	 	 	Phone: (314) 733-8112
	 

	 	 	 	Fax: (314) 733-8002
	 

	 	 	 	Email: mhermann@ascensionhealth.org
	 

	 	 	 	Attn: Jamie Wehrung
	 

	 	 	 	Phone: (314) 733-8116
	 

	 	 	 	Fax: (314) 733-8002
	 

	 	 	 	Email: jwehrung@ascensionhealth.org
	 
	 	 	 	 
	 

	 	With a copy to:
	 	Joseph R. Impicciche, Esquire
	 

	 	 	 	Senior Vice President, Legal
Services and General Counsel

	 

	 	 	 	Ascension Health
	 

	 	 	 	4600 Edmundson Rd.
	 

	 	 	 	St. Louis, MO  63134
	 

	 	 	 	Phone: (314) 733-8286
	 

	 	 	 	Fax: (314) 733-8013
	 

	 	 	 	E-mail: jimpicciche@ascensionhealth.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

HATHAWAY REVOCABLE TRUST UNDER AGREEMENT DATED FEBRUARY 10, 2005

 	 
	 	By:  	/s/
Stephen C. Hathaway 	 
	 	 	Stephen C. Hathaway, Trustee 	 
	 	 	 	 
	 
	 	 	 
	 	By:  	/s/
Elaine M. Hathaway 	 
	 	 	Elaine M. Hathaway, Trustee 	 
	 	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Stephen C. Hathaway
	 

	 	 	 	c/o TomoTherapy Incorporated
	 

	 	 	 	1240 Deming Way
	 

	 	 	 	Madison, WI 53717-1954
	 

	 	 	 	Phone: (608) 824-2838
	 

	 	 	 	Email: shathaway@tomotherapy.com 

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

STEPHEN C. HATHAWAY GRANTOR RETAINED ANNUITY TRUST

 	 
	 	By:  	/s/
Stephen C. Hathaway 	 
	 	        Stephen
C. Hathaway, Trustee 	  
	 	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Stephen C. Hathaway
	 

	 	 	 	c/o TomoTherapy Incorporated
	 

	 	 	 	1240 Deming Way
	 

	 	 	 	Madison, WI 53717-1954
	 

	 	 	 	Phone: (608) 824-2838
	 

	 	 	 	Email: shathaway@tomotherapy.com 

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

ELAINE M. HATHAWAY GRANTOR
RETAINED ANNUITY TRUST

 	 
	 	By:  	/s/
Stephen C. Hathaway 	 
	 	        Stephen
C. Hathaway, Trustee	  
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Stephen C. Hathaway
	 

	 	 	 	c/o TomoTherapy Incorporated
	 

	 	 	 	1240 Deming Way
	 

	 	 	 	Madison, WI 53717-1954
	 

	 	 	 	Phone: (608) 824-2838
	 

	 	 	 	Email: shathaway@tomotherapy.com 

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

AVALON TECHNOLOGY, LLC

 	 
	 	By:  	/s/
David Russell 	 
	 	  	David Russell 
	 	 	Executive Vice President, Avalon Captial
Group
	 

	 	 	 	 	 
	 

	 	Notices:
	 	c/o Avalon Portfolio, LLC
	 

	 	 	 	5786 LaJolla Blvd.
	 

	 	 	 	LaJolla, CA 92037
	 

	 	 	 	Attn: Jon McCloskey
	 

	 	 	 	Phone: (858) 551-4429
	 

	 	 	 	Email: jmccloskey@avalon.com 

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 	 	 
	 

	 	INVESTOR:	 	 	 	 
	 
	 	 	 	 	 	 
	 	 	ADVANTAGE CAPITAL WISCONSIN
	 	 	PARTNERS I, LIMITED PARTNERSHIP
	 
	 	 	 	 	 	 
	 	 	By: Venture Investors LLC
	 	 	Its: Sub-Manager

	 	 	 	 	 
	 	 	 
	 	By:  	/s/
John Neis 	 
	 	 	John Neis 	 
	 	 	Managing Director 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	c/o Venture Investors LLC
	 

	 	 	 	505 South Rosa Road, #100
	 

	 	 	 	Madison, WI 53719-1262
	 

	 	 	 	Attn: John Neis, Managing Director
	 

	 	 	 	Phone: (608) 441-2700
	 

	 	 	 	Fax: (608) 441-2727
	 

	 	 	 	Email: john@ventureinvestors.com 

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 	 	 
	 	 	BAIRD VENTURE PARTNERS I
	 	 	LIMITED PARTNERSHIP
	 	 	 
	 	 	By: Baird Venture Partners Management Company I, L.L.C.
	 	 	Its: General Partner

	 	 	 	 	 
	 	 	 
	 	By:  	/s/
Peter K. Shagory 	 
	 	 	Peter K. Shagory 	 
	 	 	Director 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	c/o Baird Venture Partners
	 

	 	 	 	227 West Monroe Street, 22nd Floor
	 

	 	 	 	Chicago, IL 60606-5055
	 

	 	 	 	Attn: Michael Liang
	 

	 	 	 	Phone: (312) 609-5999
	 

	 	 	 	Email: mliang@rwbaird.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 	 	 
	 	 	BVP I AFFILIATES FUND
	 	 	LIMITED PARTNERSHIP
	 
	 	 	 	 	 	 
	 	 	By: Baird Venture Partners Management Company I, L.L.C.
	 	 	Its: General Partner

	 	 	 	 	 
	 	 	 
	 	By:  	/s/
Peter K. Shagory 	 
	 	 	Peter K. Shagory 	 
	 	 	Director 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	c/o Baird Venture Partners
	 

	 	 	 	227 West Monroe Street, 22nd Floor
	 

	 	 	 	Chicago, IL 60606-5055
	 

	 	 	 	Attn: Michael Liang
	 

	 	 	 	Phone: (312) 609-5999
	 

	 	 	 	Email: mliang@rwbaird.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 	 	 
	 	 	OPEN PRAIRIE VENTURES I, L.P.
	 
	 	 	 	 	 	 
	 	 	By: Open Prairie Ventures Management I, LLC
	 	 	Its: General Partner
	 
	 	 	 	 	 	 
	 	 	By: Open Prairie Ventures, Inc.
	 	 	Its: Manager

	 	 	 	 	 
	 	 	 
	 	By:  	/s/
James M. Schultz 	 
	 	  	James M. Schultz 	 
	 	  	President 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Open Prairie Ventures
	 

	 	 	 	400 East Jefferson, P.O. Box 187
	 

	 	 	 	Effingham, IL 62401
	 

	 	 	 	Attn: Jim Schultz
	 

	 	 	 	Phone: (217) 347-1010
	 

	 	 	 	Fax: (217) 347-1001
	 

	 	 	 	Email: jschultz@openprairie.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

THE ENDEAVORS GROUP, LLC

 	 
	 	By:  	/s/
Kevin Lindsey 	 
	 	 	Kevin Lindsey 	 
	 	 	Manager 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	The Endeavors Group, LLC
	 

	 	 	 	Attn: Kevin Lindsey
	 

	 	 	 	9100 N. Swan Rd.
	 

	 	 	 	Milwaukee, WI 53224-1704
	 

	 	 	 	Phone: (414) 355-3000
	 

	 	 	 	Fax: (414) 355-8060
	 

	 	 	 	Email: klindsey@execpc.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

780 TOMOTHERAPY PARTNERS

 	 
	 	By:  	/s/
Michael E. Skindrud 	 
	 	 	Michael E. Skindrud 	 
	 	 	Partner 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	c/o Godfrey & Kahn
	 

	 	 	 	One East Main Street, Suite 500
	 

	 	 	 	Madison, WI 53703
	 

	 	 	 	Attn: Michael E. Skindrud
	 

	 	 	 	Phone: (608) 284-2619
	 

	 	 	 	Fax: (608) 257-0609
	 

	 	 	 	Email: mskindrud@gklaw.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

SKL INVESTMENT GROUP, LLC

 	 
	 	By:  	/s/
Steve Grissom 	 
	 	 	Steve Grissom, Administrative Officer 	 
	 	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	SKL Investment Group, LLC
	 

	 	 	 	121 S. 17th Street
	 

	 	 	 	Mattoon, IL 61938
	 

	 	 	 	Attn: Steve Grissom
	 

	 	 	 	Phone: (217) 235-4410
	 

	 	 	 	Email: steven.grissom@consolidated.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

AKRA INVESTMENTS, LLC

 	 
	 	By:  	/s/
Bob Schultz 	 
	 	 	Bob Schultz, President 	 
	 	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	c/o Schultz Investment Company
	 

	 	 	 	PO Box 218
	 

	 	 	 	Effingham, IL 62401
	 

	 	 	 	Attn: Bob Schultz
	 

	 	 	 	Phone: (217) 342-0802
	 

	 	 	 	Email: bschultz@schultzusa.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	 INVESTOR:	 	 
	 	 	 
	 	Wade Fetzer III
	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Wade Fetzer III
	 

	 	 	 	c/o Goldman, Sachs & Co.
	 

	 	 	 	4900 Sears Tower
	 

	 	 	 	Chicago, IL 60606-6372
	 

	 	 	 	Email: wade.fetzer@gs.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

 	 
	 	 	 
	 	Frank J. Gambino 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Frank J. Gambino
	 

	 	 	 	1007 Farwell Court
	 

	 	 	 	Madison, WI 53704
	 

	 	 	 	Phone: (608) 240-9639
	 

	 	 	 	Email: fgambino@rwbaird.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	 INVESTOR:

 	 
	 	 	 
	 	David A. Hackworthy 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	David A. Hackworthy
	 

	 	 	 	639 Summit Road
	 

	 	 	 	Madison, WI 53704
	 

	 	 	 	Phone: (608) 241-2988
	 

	 	 	 	Email: dhackworthy-jr@rwbaird.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

HACKWORTHY FAMILY TRUST

DATED MAY 24, 2003

 	 
	 	By:  	 	 
	 	 	Patricia A. Hackworthy, Trustee 	 
	 	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	2136 Van Hise Avenue
	 

	 	 	 	Madison, WI 53705
	 

	 	 	 	Phone: (608) 233-4400
	 

	 	 	 	Or
	 

	 	 	 	P.O. Box 392
	 

	 	 	 	Madison, WI 53701-0392
	 

	 	 	 	Phone: (608) 251-2351
	 

	 	 	 	Email: dhackworthy-jr@rwbaird.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

 	 
	 	/s/ Terry F. Kelly	 
	 	Terry F. Kelly 	 
	 	 	 
	 

	 	 	 	 	 
	 	 	 
	 	/s/ Mary W. Kelly 	 
	 	Mary W. Kelly 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Terry F. and Mary W. Kelly
	 

	 	 	 	1007 Hillside Avenue
	 

	 	 	 	Madison, WI 53705-1116
	 

	 	 	 	Phone (work): (608) 274-5789
	 

	 	 	 	Phone (home): (608) 238-3734
	 

	 	 	 	Email: tkelly@wxc.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	 INVESTOR:

 	 
	 	 	 
	 	Thomas S. King 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Thomas S. King
	 

	 	 	 	3582 Bishops Way
	 

	 	 	 	Middleton, WI 53562
	 

	 	 	 	Phone: (608) 242-4100 ext. 30373
	 

	 	 	 	Email: tkin1@amfam.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

GREY GHOST, LLC

 	 
	 	By:  	 	 
	 	 	 	 
	 	Name: 	 	 
	 	 	 	 
	 	Title:  	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Max G. and Shelley M. Lagally
	 

	 	 	 	5110 Juneau Road
	 

	 	 	 	Madison, WI 53705-4744
	 

	 	 	 	Phone: (608) 233-0071
	 

	 	 	 	Email: lagally@neep.engr.wisc.edu

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement r as
of the date first written above.

	 	 	 	 	 
	 	 INVESTOR:

 	 
	 	 	 
	 	Michael G. Laskis 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Michael G. Laskis
	 

	 	 	 	c/o Foley & Lardner
	 

	 	 	 	150 E. Gilman Street, PO Box 1497
	 

	 	 	 	Madison, WI 53701-1497
	 

	 	 	 	Phone: (608) 257-5035
	 

	 	 	 	Fax: (608) 258-4258
	 

	 	 	 	Email: mlaskis@foleylaw.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

 	 
	 	/s/ Kevin Lindsey	 
	 	Kevin Lindsey 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Kevin Lindsey
	 

	 	 	 	c/o The Endeavors Group, LLC
	 

	 	 	 	9100 N. Swan Road
	 

	 	 	 	Milwaukee, WI 53224-1704
	 

	 	 	 	Phone: (414) 355-3000
	 

	 	 	 	Fax: (414) 355-8060
	 

	 	 	 	Email: klindsey@execpc.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	 INVESTOR:

 	 
	 	 	 
	 	John J. McDonough 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	c/o McDonough Medical Products Corp.
	 

	 	 	 	1407 Barclay Boulevard
	 

	 	 	 	Buffalo Grove, IL 60089
	 

	 	 	 	Phone: (847) 325-9774
	 

	 	 	 	Fax: (847) 541-8452
	 

	 	 	 	Email: jmcdono286@aol.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	 INVESTOR:

 	 
	 	 	 
	 	Allison J. McDonough 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Allison J. McDonough
	 

	 	 	 	756 Mawman Avenue
	 

	 	 	 	Lake Bluff, IL 60044
	 

	 	 	 	Phone: (847) 615-9432
	 

	 	 	 	Fax: (312) 215-5080
	 

	 	 	 	Email: ejm101658@aol.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

 	 
	 	 	 
	 	Edwin J. McDonough
 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	c/o McDonough Medical Products Corp.
	 

	 	 	 	1407 Barclay Boulevard
	 

	 	 	 	Buffalo Grove, IL 60089
	 

	 	 	 	Phone: (847) 325-9774
	 

	 	 	 	Fax: (847) 541-8452
	 

	 	 	 	Email: ejm@mcdonoughmedical.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	 INVESTOR:

 	 
	 	 	 
	 	John J. McDonough, Jr. 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	John J. McDonough, Jr.
	 

	 	 	 	8225 Cobblestone Drive
	 

	 	 	 	Austin, TX 78735
	 

	 	 	 	Phone: (512) 394-0329
	 

	 	 	 	Fax: (512) 418-0111
	 

	 	 	 	Email: johnmcdonough1@mac.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	 INVESTOR:

 	 
	 	 	 
	 	Joseph F. McDonough 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Joseph F. McDonough
	 

	 	 	 	6990 Apprentice Place
	 

	 	 	 	Middleton, WI 53562
	 

	 	 	 	Phone: (608) 831-2292
	 

	 	 	 	Fax: (425) 645-0313
	 

	 	 	 	E-mail: joe@joemcdonough.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	 INVESTOR:

 	 
	 	 	 
	 	Dana L. McDonough 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Dana L. McDonough
	 

	 	 	 	310 Ravine Forest Drive
	 

	 	 	 	Lake Bluff, IL 60045
	 

	 	 	 	Phone: (847) 735-9772
	 

	 	 	 	Fax: (847) 735-9678
	 

	 	 	 	Email: mcdonod@comcast.net

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

 	 
	 	/s/ Cary J. Nolan	 
	 	Cary J. Nolan 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Cary J. Nolan
	 

	 	 	 	10028 Hobart Road
	 

	 	 	 	Kirtland, OH 44094-9723
	 

	 	 	 	Phone: (440) 256-3903/3904
	 

	 	 	 	Fax: (440) 256-2900
	 

	 	 	 	Fax (winter): (949) 376-4554
	 

	 	 	 	Mobile: (216) 314-5651
	 

	 	 	 	Email: cnolan95@aol.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

ARDESTA EMPLOYEES’ 401(K) SAVINGS &

INVESTMENT PLAN F/B/O CHRISTOPHER RIZIK

 	 
	 	By:  	/s/ Christopher L. Rizik	 
	 	 	Christopher L. Rizik, Trustee 	 
	 	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Christopher L. Rizik
	 

	 	 	 	c/o Ardesta Employees’ 401(k) Savings &
	 

	 	 	 	Investment Plan
	 

	 	 	 	201 S. Main Street, Suite 1000
	 

	 	 	 	Ann Arbor, MI 48104
	 

	 	 	 	Email: chrisrizik@ardesta.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:	 
	 	 	 
	 	/s/ Anne E. Ross	 
	 	Anne E. Ross 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Anne E. Ross
	 

	 	 	 	c/o Foley & Lardner
	 

	 	 	 	150 E. Gilman Street, PO Box 1497
	 

	 	 	 	Madison, WI 53701-1497
	 

	 	 	 	Phone: (608) 257-5035
	 

	 	 	 	Fax: (608) 258-4258
	 

	 	 	 	Email: aross@foleylaw.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

RONALD D. SIPPEL REVOCABLE TRUST

 	 
	 	By:  	 	 
	 	 	Ronald D. Sippel, Trustee 	 
	 	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Ronald D. Sippel
	 

	 	 	 	1312 Church Street
	 

	 	 	 	Evanston, IL 60201
	 

	 	 	 	Phone: (312) 559-8891
	 

	 	 	 	Email: rsippel@usa.net

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

 	 
	 	 	 
	 	Dennis Skogen 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Dennis Skogen
	 

	 	 	 	3154 Wacheeta Trail
	 

	 	 	 	Madison, WI 53711-5952
	 

	 	 	 	Phone: (608) 222-8600
	 

	 	 	 	Email: dennis@skogen.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

RICHARD D. SNYDER REVOCABLE TRUST

 	 
	 	By:  	/s/
Richard D. Snyder
 	 
	 	 	Richard D. Snyder, Trustee 	 
	 	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	c/o Richard D. Snyder
	 

	 	 	 	201 S. Main Street, Suite 1000
	 

	 	 	 	Ann Arbor, MI 48104

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

 	 
	 	 	 
	 	Marc Vaintrub 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Marc Vaintrub
	 

	 	 	 	843 West Webster Avenue
	 

	 	 	 	Chicago, IL 60614
	 

	 	 	 	Phone: (773) 525-1791
	 

	 	 	 	Email: marc@vaintrub.org

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	 INVESTOR:

 	 
	 	 	 
	 	David G. Walsh 	 
	 	 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	David G. Walsh
	 

	 	 	 	c/o Foley & Lardner
	 

	 	 	 	150 E. Gilman Street
	 

	 	 	 	Madison, WI 53703-2808
	 

	 	 	 	Phone: (608) 257-5035
	 

	 	 	 	Fax: (608) 258-4258
	 

	 	 	 	Email: dwalsh@foleylaw.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

ALLAN A. WEISSBURG REVOCABLE TRUST

 	 
	 	By:  	/s/
Allan A. Weissburg
	 
	 	 	Allan A. Weissburg, Trustee 	 
	 	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	c/o Allan A. Weissburg
	 

	 	 	 	11502 Hemingway Drive
	 

	 	 	 	Reston, VA 20194-1252
	 

	 	 	 	Phone: (703) 467-9855
	 

	 	 	 	Email: allan@weissburg.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

DAVID WEISSBURG AND

LESLIE WEISSBURG, AS JOINT TENANTS WITH RIGHT OF SURVIVORSHIP

 	 
	 	 	 
	 	David Weissburg 	 
	 	 	 
	 
	 	 	 
	 	 	 
	 	Leslie Weissburg 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	c/o David Weissburg
	 

	 	 	 	4213 Winnequah Road
	 

	 	 	 	Monona, WI 53716-1057
	 

	 	 	 	Phone: (608) 221-0023
	 

	 	 	 	Fax: (608) 221-9055
	 

	 	 	 	Email: david@weissburg.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

 	 
	 	 	 
	 	David Weissburg 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	David Weissburg
	 

	 	 	 	4213 Winnequah Road
	 

	 	 	 	Monona, WI 53716-1057
	 

	 	 	 	Phone: (608) 221-0023
	 

	 	 	 	Fax: (608) 221-9055
	 

	 	 	 	Email: david@weissburg.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

 	 
	 	 	 
	 	Leslie Weissburg 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	c/o David Weissburg
	 

	 	 	 	4213 Winnequah Road
	 

	 	 	 	Monona, WI 53716-1057
	 

	 	 	 	Phone: (608) 221-0023
	 

	 	 	 	Fax: (608) 221-9055
	 

	 	 	 	Email: david@weissburg.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

STATE OF WISCONSIN

INVESTMENT BOARD

 	 
	 	By:  	/s/
Chris Prestigiacomo
 	 
	 	 	Chris Prestigiacomo 	 
	 	 	Portfolio Manager 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	121 East Wilson Street
	 

	 	 	 	Madison, WI 53702
	 

	 	 	 	Attn: Chris Prestigiacomo, Portfolio Manager
	 

	 	 	 	Phone: (608) 266-6723
	 

	 	 	 	Fax: (608) 266-2436
	 

	 	 	 	Email: chris.prestigiacomo@swib.state.wi.us 

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 	 	 
	 	 	VENTURE INVESTORS EARLY STAGE FUND
	 	 	II LIMITED PARTNERSHIP
	 
	 	 	 	 	 	 
	 	 	By: Venture Investors Founders, L.P.
	 	 	Its: General Partner
	 
	 	 	 	 	 	 
	 	 	By: Venture Investors LLC
	 	 	Its: General Partner

	 	 	 	 	 
	 	 	 
	 	By:  	/s/
John Neis 	 
	 	 	John Neis 	 
	 	 	Managing Director 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	c/o Venture Investors LLC
	 

	 	 	 	505 South Rosa Road, #100
	 

	 	 	 	Madison, WI 53719-1262
	 

	 	 	 	Attn: John Neis, Managing Director
	 

	 	 	 	Phone: (608) 441-2700
	 

	 	 	 	Fax: (608) 441-2727
	 

	 	 	 	Email: john@ventureinvestors.com

     [Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 	 	 
	 	 	INVESTOR:
	 
	 	 	 	 	 	 
	 	 	VENTURE INVESTORS EARLY STAGE FUND

III LIMITED PARTNERSHIP
	 
	 	 	 	 	 	 
	 	 	By: Venture Investors LLC
	 	 	Its: General Partner

	 	 	 	 	 
	 	 	 
	 	By:  	/s/
John Neis 	 
	 	 	John Neis 	 
	 	 	Managing Director 	 
	 

	 	 	 	 	 
	 	 	Notices:
	 	 
	 

	 	 	 	505 South Rosa Road, #100
	 

	 	 	 	Madison, WI 53719-1262
	 

	 	 	 	Attn: John Neis, Managing Director
	 

	 	 	 	Phone: (608) 441-2700
	 

	 	 	 	Fax: (608) 441-2727
	 

	 	 	 	Email: john@ventureinvestors.com

[Signature
 to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

WISCONSIN ALUMNI RESEARCH FOUNDATION

 	 
	 	By:  	/s/
Carl E. Gulbrandsen
 	 
	 	 	Carl E. Gulbrandsen 	 
	 	 	Managing Director 	 
	 

	 	 	 	 	 
	 	 	 
	 	By:  	/s/
Carrie J. Thome
 	 
	 	 	Carrie J. Thome 	 
	 	 	Associate Director of Investments 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	614 Walnut Street (53705)
	 

	 	 	 	P.O. Box 7365
	 

	 	 	 	Madison, WI 53707-7365
	 

	 	 	 	Attn: Carrie J. Thome, Associate Director of
	 

	 	 	 	Investments
	 

	 	 	 	Phone: (608) 263-2500
	 

	 	 	 	Fax: (608) 263-1064
	 

	 	 	 	Email: cthome@warf.ws

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

 	 
	 	/s/
James Hanson
 	 
	 	James Hanson 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	James Hanson
	 

	 	 	 	3440 Highpoint Road
	 

	 	 	 	Madison, WI 53719
	 

	 	 	 	Phone (Mobile): (608) 358-0500
	 

	 	 	 	Email: jimhanson@tds.net

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

 	 
	 	 	 
	 	P. Schaefer Price 	 
	 	 	 
	 
	 	 	 
	 	 	 
	 	Amy J. Price 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	P. Schaefer and Amy J. Price
	 

	 	 	 	c/o Pharmasset
	 

	 	 	 	303 College Road East
	 

	 	 	 	Princeton, NJ 08540
	 

	 	 	 	Phone: (404) 325-5183
	 

	 	 	 	Email: sprice@pharmasset.com

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

MAYO FOUNDATION FOR MEDICAL

EDUCATION AND RESEARCH

 	 
	 	By:  	/s/
Steven P. VanNurden 	 
	 	Name:  	Steven P. VanNurden 	 
	 	Its:  	Assistant
Treasurer 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Attn: Nathan L. Stacy
	 

	 	 	 	Mayo Medical Ventures
	 

	 	 	 	200 First Street, S.W.
	 

	 	 	 	Rochester, MN 55905
	 

	 	 	 	Phone: (507) 538-1652
	 

	 	 	 	Fax: (507) 284-5410
	 

	 	 	 	E-mail: stacy.nathan@mayo.edu

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

SUNSHINE SUMMIT, LLC

 	 
	 	By:  	/s/
Jose Luis Pino-y-Torres 	 
	 	Its:  	President 	 
	 	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	Attn: Dr. Jose Luis Pino-y-Torres
	 

	 	 	 	22 Shady Lane
	 

	 	 	 	Sparta, NJ 07871
	 

	 	 	 	Phone: (973) 726-8718
	 

	 	 	 	Mobile: (407) 367-9731
	 

	 	 	 	Email: pinoytorres@earthlink.net

[Signature Page to Amendment and Waiver Agreement]

 

 

     IN WITNESS WHEREOF, the parties hereto have executed this Amendment and Waiver Agreement as of
the date first written above.

	 	 	 	 	 
	 	INVESTOR:

 	 
	 	 	 
	 	John J. Barni 	 
	 	 	 
	 

	 	 	 	 	 
	 

	 	Notices:
	 	John J. Barni
	 

	 	 	 	900 W. Hill Drive
	 

	 	 	 	Gates Mills, OH 44040-9684
	 

	 	 	 	Home: (440) 423-0747
	 

	 	 	 	Mobile: (440) 655-3889
	 

	 	 	 	Email: vwbug66@sbcglobal.net

[Signature Page to Amendment and Waiver Agreement]

 

 

EXHIBIT A

Investors

Reckwerdt, Paul J.

Barni, John

Stephen C. Hathaway and Elaine M. Hathaway, as

     Trustees of the Hathaway Revocable Trust under

     agreement dated February 10, 2005

Stephen C. Hathaway Grantor Retained Annuity Trust

Elaine M. Hathaway Grantor Retained Annuity Trust

Avalon Technology, LLC

Wisconsin Alumni Research Foundation

Venture Investors Early Stage Fund III L.P.

Venture Investors Early Stage Fund II L.P.

Advantage Capital Wisconsin Partners I, L.P.

Open Prairie Ventures I, L.P.

Mayo Foundation for Medical Education and Research

Endeavors Group, LLC, The

AKRA Investments, LLC

Ardesta Employees’ 401(k) Savings & Retirement

     Plan, f/b/o Christopher Rizik

Ascension Health

780 TomoTherapy Partners

Baird Venture Partners I L.P.

BVP I Affiliates Fund L.P.

Fetzer III, Wade

Gambino, Frank J.

Grey Ghost LLC

Hackworthy, David A.

Hackworthy Family Trust

Hanson, James

Kelly, Terry F. and Mary W.

King, Thomas S.

Laskis, Michael G.

Lindsey, Kevin

McDonough, John J.

McDonough, Allison J.

McDonough, Edwin J.

McDonough, John J. Jr.

McDonough, Joseph F.

McDonough, Dana L.

Nolan, Cary

Price, P. Schaefer and Amy J.

Ross, Anne E.

Ronald D. Sippel Revocable Trust

A-1

 

SKL Investment Group, LLC

Skogen, Dennis

Richard D. Snyder Revocable Trust

Sunshine Summit, LLC

Vaintrub, Marc

Walsh, David G.

Weissburg, Allan A. Revocable Trust

Weissburg, David and Leslie, as joint tenants with

     right of survivorship

Weissburg, David

Weissburg, Leslie

State of Wisconsin Investment Board

A-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00129-of-00352.parquet"}]]